SPRT, THOR, TKMR - CRWESelect.com Stock News! support.com, Thoratec Corporation, Tekmira Pharmaceuticals Corporation (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) February 9, 2012 -- To view video, and read the full article visit URL http://crweselect.com/28533/stock-alerts/sprt-thor-tkmr-crweselectcom-stock-news-supportcom-thoratec-corporation-tekmira-pharmaceuticals-corporation-video-included-inside/

support.com, Inc. (NASDAQ: SPRT)

Support.com, Inc. - Symbol SPRT - reported unaudited financial results for its fourth quarter ended December 31, 2011. For the fourth quarter of 2011, total revenue was $15.0 million compared to $12.4 million in the third quarter of 2011 and $12.3 million in the fourth quarter of 2010.

SPRT provides cloud-based technology services and software for consumers and small business. Support.com Personal Technology Experts® provide a quick, cost-effective and stress-free technology support experience over the Internet and the phone using the Company's advanced technology platform. Support.com also offers a wide range of easy-to-use software products that detect and repair common computer problems and optimize performance and security. Support.com offers programs through many of the nation's leading retailers, broadband service providers, software vendors and PC/CE OEMs, and provides software to over a million consumers and small businesses.

For more information about SPRT please visit http://www.support.com

****

Thoratec Corporation (NASDAQ: THOR)

Thoratec Corporation - Symbol THOR - announced that revenues for the fourth quarter of 2011 were $109.4 million, a 12 percent increase over revenues of $97.6 million in the same period a year ago.

THOR is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate LVAS (Left Ventricular Assist System) and Thoratec VAD (Ventricular Assist Device) with more than 18,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag and PediMag / PediVAS product lines. Thoratec is headquartered in Pleasanton, California.

For more information about THOR please visit http://www.thoratec.com

****

Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR)

Tekmira Pharmaceuticals Corporation - Symbol TKMR - announced that the United States Patent & Trademark Office (USPTO) has recently issued two key patents expanding its intellectual property portfolio: one covers its lipid nanoparticle (LNP) delivery technology (U.S. Patent No. 8,058,069), and the other covers the chemical modification of siRNA to mitigate immune stimulation (U.S. Patent No. 8,101,741).

TKMR is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Tekmira has been working in the field of nucleic acid delivery for over a decade and has broad intellectual property covering LNPs.

For more information about TKMR please visit http://www.tekmirapharm.com

To read the full article visit URL http://crweselect.com/28533/stock-alerts/sprt-thor-tkmr-crweselectcom-stock-news-supportcom-thoratec-corporation-tekmira-pharmaceuticals-corporation-video-included-inside/

*****************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

SPRTcrweselect0209
THORcrweselect0209
TKMRcrweselect0209

lipid nanoparticle     select     SPRT     Tekmira Pharmaceuticals Corp.     thor     Thoratec Corporation     TKMR